Involvement of MicroRNA-423 Gene Variability in Breast Cancer Progression in Saudi Arabia

Overview

Journal Asian Pac J Cancer Prev

Specialty Oncology

Date 2018 Sep 27

PMID 30256064

Citations 12

Authors

R Mir

I A Al Balawi

F M Abu Duhier

Affiliations

Soon will be listed here.

Abstract

Aim: microRNA-423 is an oncogenic factor which is frequently upregulated in cancer. However, associations with breast cancer risk remain inconsistent. Therefore, we investigated the prevalence of microRNA-423 rs6505162C>T gene variation with breast cancer susceptibility in Saudi women. Methodology: This study was conducted on 100 breast cancer patients and 124 matched healthy individuals. Genotyping of the microRNA-423 rs6505162C/T gene variation was performed by using the amplification refractory mutation system PCR method (ARMS-PCR). Results: A significant difference was observed in the genotype distribution between the breast cancer cases and controls (p=0.0001), the frequencies of the genotypes CC,CT and TT being 25%, 52% and 23% in patients and 65%,20% and 15% respectively, in controls. The microRNA-423 C>T variant was associated with an increased risk of breast cancer in codominant models for (OR = 6.73, 95 % CI, 3.50-12.97; RR 2.35(1.67-3.30, p=0.0001) the microRNA-423TT genotype and (OR = 4.14, 95 % CI, 1.93-8.87; p=0.0003) microRNA-423CT (OR= 6.73, 95% CI, 3.50-12.97; p=0.0001) and also with the dominant model (OR 5.6(3.14-1.01), p=0.0001) CT+TT vs CC) with a non-significant association for the recessive model (OR=1.75, 95%CI=0.08-3.44, P=0.139, TT vs CC+CT). The T allele significantly increased the risk of breast cancer (OR =2.63, 95 % CI, 1.77-3.91; p=0.001) compared to the C allele. Some 6.73 ,4.14 and 2.63 fold increased risk of developing breast cancer was associated with TT and CT genotypes and the T allele of microRNA-423 in the northwestern region of Saudi Arabia. Conclusion: Our findings indicate that the microRNA-423 TT genotype and the T allele are associated with an increased susceptibility, metastasis and advanced stage of breast cancer in Saudi Arabian patients. Further studies with larger sample sizes are necessary to confirm our findings.

Citing Articles

A systematic review of candidate genes and their relevant pathways for metastasis among adults diagnosed with breast cancer.

Gehling G, Alfaqih M, Pruinelli L, Starkweather A, Dungan J Breast Cancer Res. 2024; 26(1):165.

PMID: 39593069 PMC: 11590482. DOI: 10.1186/s13058-024-01914-6.

Visualizing breast cancer research trends in KSA: A bibliometric analysis.

Al-Kahtani R, Mahmood N, Aamir S, Anjum Z J Taibah Univ Med Sci. 2023; 18(6):1472-1479.

PMID: 37409243 PMC: 10318506. DOI: 10.1016/j.jtumed.2023.06.003.

Influence of Micro-RNA-423 Gene Variation on Risk and Characteristics of Breast Cancer.

El-Ashry A, Albeltagy A, Ramez A, Hendawy S Asian Pac J Cancer Prev. 2022; 23(11):3771-3777.

PMID: 36444590 PMC: 9930970. DOI: 10.31557/APJCP.2022.23.11.3771.

Molecular Determination of Vascular Endothelial Growth Factor, miRNA-423 Gene Abnormalities by Utilizing ARMS-PCR and Their Association with Fetal Hemoglobin Expression in the Patients with Sickle Cell Disease.

Hamadi A, Mir R, Mahzari A, Hakami A, Almotairi R, Dobie G Curr Issues Mol Biol. 2022; 44(6):2569-2582.

PMID: 35735616 PMC: 9221959. DOI: 10.3390/cimb44060175.

Genetic Variation in MicroRNA-423 Promotes Proliferation, Migration, Invasion, and Chemoresistance in Breast Cancer Cells.

Morales-Pison S, Jara L, Carrasco V, Gutierrez-Vera C, Reyes J, Gonzalez-Hormazabal P Int J Mol Sci. 2022; 23(1).

PMID: 35008806 PMC: 8745459. DOI: 10.3390/ijms23010380.

References

Smith R, Jedlinski D, Gabrovska P, Weinstein S, Haupt L, Griffiths L . A genetic variant located in miR-423 is associated with reduced breast cancer risk. Cancer Genomics Proteomics. 2012; 9(3):115-8. View

Morales S, Gulppi F, Gonzalez-Hormazabal P, Fernandez-Ramires R, Bravo T, Reyes J . Association of single nucleotide polymorphisms in Pre-miR-27a, Pre-miR-196a2, Pre-miR-423, miR-608 and Pre-miR-618 with breast cancer susceptibility in a South American population. BMC Genet. 2016; 17(1):109. PMC: 4946190. DOI: 10.1186/s12863-016-0415-0. View

Calin G, Sevignani C, Dumitru C, Hyslop T, Noch E, Yendamuri S . Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A. 2004; 101(9):2999-3004. PMC: 365734. DOI: 10.1073/pnas.0307323101. View

Lerman G, Avivi C, Mardoukh C, Barzilai A, Tessone A, Gradus B . MiRNA expression in psoriatic skin: reciprocal regulation of hsa-miR-99a and IGF-1R. PLoS One. 2011; 6(6):e20916. PMC: 3110257. DOI: 10.1371/journal.pone.0020916. View

Kontorovich T, Levy A, Korostishevsky M, Nir U, Friedman E . Single nucleotide polymorphisms in miRNA binding sites and miRNA genes as breast/ovarian cancer risk modifiers in Jewish high-risk women. Int J Cancer. 2009; 127(3):589-97. DOI: 10.1002/ijc.25065. View

Mokdad A, Jaber S, Aziz M, AlBuhairan F, AlGhaithi A, AlHamad N . The state of health in the Arab world, 1990-2010: an analysis of the burden of diseases, injuries, and risk factors. Lancet. 2014; 383(9914):309-20. DOI: 10.1016/S0140-6736(13)62189-3. View

Li C, Zhang Y, Li Y, Ma Q, Liu S, Yao Y . The association of polymorphisms in miRNAs with nonsmall cell lung cancer in a Han Chinese population. Cancer Manag Res. 2018; 10:697-704. PMC: 5901134. DOI: 10.2147/CMAR.S154040. View

He B, Pan Y, Xu Y, Deng Q, Sun H, Gao T . Associations of polymorphisms in microRNAs with female breast cancer risk in Chinese population. Tumour Biol. 2015; 36(6):4575-82. DOI: 10.1007/s13277-015-3102-2. View

Ali S, Saleh H, Sethi S, Sarkar F, Philip P . MicroRNA profiling of diagnostic needle aspirates from patients with pancreatic cancer. Br J Cancer. 2012; 107(8):1354-60. PMC: 3494446. DOI: 10.1038/bjc.2012.383. View

10.

Lin J, Huang S, Wu S, Ding J, Zhao Y, Liang L . MicroRNA-423 promotes cell growth and regulates G(1)/S transition by targeting p21Cip1/Waf1 in hepatocellular carcinoma. Carcinogenesis. 2011; 32(11):1641-7. DOI: 10.1093/carcin/bgr199. View

11.

Hui A, Lenarduzzi M, Krushel T, Waldron L, Pintilie M, Shi W . Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas. Clin Cancer Res. 2010; 16(4):1129-39. DOI: 10.1158/1078-0432.CCR-09-2166. View

12.

Mehrgou A, Akouchekian M . The importance of BRCA1 and BRCA2 genes mutations in breast cancer development. Med J Islam Repub Iran. 2016; 30:369. PMC: 4972064. View

13.

Boren T, Xiong Y, Hakam A, Wenham R, Apte S, Wei Z . MicroRNAs and their target messenger RNAs associated with endometrial carcinogenesis. Gynecol Oncol. 2008; 110(2):206-15. DOI: 10.1016/j.ygyno.2008.03.023. View

14.

Carthew R . Gene regulation by microRNAs. Curr Opin Genet Dev. 2006; 16(2):203-8. DOI: 10.1016/j.gde.2006.02.012. View

15.

McGuire A, Brown J, Malone C, McLaughlin R, Kerin M . Effects of age on the detection and management of breast cancer. Cancers (Basel). 2015; 7(2):908-29. PMC: 4491690. DOI: 10.3390/cancers7020815. View

16.

Kim Y, Lee J, Oh K, Araki M, Araki K, Yamamura K . NSrp70 is a novel nuclear speckle-related protein that modulates alternative pre-mRNA splicing in vivo. Nucleic Acids Res. 2011; 39(10):4300-14. PMC: 3105421. DOI: 10.1093/nar/gkq1267. View

17.

Roy R, Singh R, Chattopadhyay E, Ray A, De Sarkar N, Aich R . MicroRNA and target gene expression based clustering of oral cancer, precancer and normal tissues. Gene. 2016; 593(1):58-63. DOI: 10.1016/j.gene.2016.08.011. View

18.

Chang S, He S, Qiu G, Lu J, Wang J, Liu J . MicroRNA-125b promotes invasion and metastasis of gastric cancer by targeting STARD13 and NEU1. Tumour Biol. 2016; 37(9):12141-12151. DOI: 10.1007/s13277-016-5094-y. View

19.

Ma F, Zhang P, Lin D, Yu D, Yuan P, Wang J . There is no association between microRNA gene polymorphisms and risk of triple negative breast cancer in a Chinese Han population. PLoS One. 2013; 8(3):e60195. PMC: 3608627. DOI: 10.1371/journal.pone.0060195. View

20.

Xie L, Sadovsky Y . The function of miR-519d in cell migration, invasion, and proliferation suggests a role in early placentation. Placenta. 2016; 48:34-37. PMC: 5130096. DOI: 10.1016/j.placenta.2016.10.004. View